Literature DB >> 22935407

Fatigue in multiple sclerosis - a brief review.

Isuru Induruwa1, Cris S Constantinescu, Bruno Gran.   

Abstract

Fatigue is the most common and debilitating symptom in multiple sclerosis (MS) and is believed to be distinctly different from fatigue seen in other chronic conditions. It can affect a patient's mood, sleep and have a detrimental effect on their quality of life. In the recent years much literature has emerged in an attempt to elucidate the potential causes and treatment of this common symptom. This review article aims to examine the most recent theories on the pathophysiology of fatigue in MS as well as its association with sleep and depression. We describe the pharmacological and non-pharmacological approaches to its treatment and propose a multidisciplinary, patient enabled and individualised manner to the management of fatigue in MS.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22935407     DOI: 10.1016/j.jns.2012.08.007

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  58 in total

Review 1.  Menopause in multiple sclerosis: therapeutic considerations.

Authors:  Riley Bove; Tanuja Chitnis; Maria Houtchens
Journal:  J Neurol       Date:  2013-10-08       Impact factor: 4.849

2.  Amantadine: multiple sclerosis-related fatigue.

Authors:  Joyce A Generali; Dennis J Cada
Journal:  Hosp Pharm       Date:  2014-09

3.  Comparison of Sleep Problems in Individuals with Spinal Cord Injury and Multiple Sclerosis.

Authors:  Donald J Fogelberg; Abbey J Hughes; Michael V Vitiello; Jeanne M Hoffman; Dagmar Amtmann
Journal:  J Clin Sleep Med       Date:  2016-05-15       Impact factor: 4.062

Review 4.  Modafinil for the Improvement of Patient Outcomes Following Traumatic Brain Injury.

Authors:  Amne Borghol; Michael Aucoin; Ifeanyichukwu Onor; Dana Jamero; Fadi Hawawini
Journal:  Innov Clin Neurosci       Date:  2018-04-01

5.  Managing Neuropsychological Impairment in Multiple Sclerosis: Pilot Study on a Standardized Metacognitive Intervention.

Authors:  Jana Pöttgen; Stephanie Lau; Iris Penner; Christoph Heesen; Steffen Moritz
Journal:  Int J MS Care       Date:  2015 May-Jun

6.  Efficacy of inpatient personalized multidisciplinary rehabilitation in multiple sclerosis: behavioural and functional imaging results.

Authors:  Priska Zuber; Charidimos Tsagkas; Athina Papadopoulou; Laura Gaetano; Manuel Huerbin; Emanuel Geiter; Anna Altermatt; Katrin Parmar; Thierry Ettlin; Corina Schuster-Amft; Zorica Suica; Hala Alrasheed; Jens Wuerfel; Jürg Kesselring; Ludwig Kappos; Till Sprenger; Stefano Magon
Journal:  J Neurol       Date:  2020-03-02       Impact factor: 4.849

7.  Predictors of Fatigue Impact in Persons With Long-Standing Multiple Sclerosis.

Authors:  Janet D Morrison; Alexa K Stuifbergen
Journal:  J Neurosci Nurs       Date:  2016-06       Impact factor: 1.230

8.  Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.

Authors:  Peter M Grace; Lisa C Loram; John P Christianson; Keith A Strand; Johanna G Flyer-Adams; Kathryn R Penzkover; John R Forsayeth; Anne-Marie van Dam; Melissa J Mahoney; Steven F Maier; Raymond A Chavez; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2016-05-14       Impact factor: 7.217

9.  Fatigue and fluid hydration status in multiple sclerosis: A hypothesis.

Authors:  Molly C Cincotta; Matthew M Engelhard; Makela Stankey; Myla D Goldman
Journal:  Mult Scler       Date:  2016-08-19       Impact factor: 6.312

10.  Dilated perivascular spaces and fatigue: is there a link? Magnetic resonance retrospective 3Tesla study.

Authors:  Renata Conforti; Mario Cirillo; Angela Sardaro; Giuseppina Caiazzo; Alberto Negro; Antonella Paccone; Rosaria Sacco; Maddalena Sparaco; Antonio Gallo; Luigi Lavorgna; Gioacchino Tedeschi; Sossio Cirillo
Journal:  Neuroradiology       Date:  2016-07-16       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.